Serial Number | 76366881 |
Word Mark | TITAN PHARMACEUTICALS |
Filing Date | Tuesday, February 5, 2002 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Saturday, April 7, 2007 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, August 19, 2003 |
Disclaimer with Predetermined Text | "PHARMACEUTICALS" |
Goods and Services | Housemark for pharmaceutical components; pharmaceuticals, namely, treatment for central nervous disorders, cancer, hematological disorders, endocrine disorders, metabolic disorders, inflammatory disorders, gastrointestinal disorders, liver disease, heart disorders, lung and bronchial disease, blood cardiovascular diseases, circulatory system disease, intestinal disorders, bone disease, autoimmune disorders and disorders of the immune systems, infectious disease and enzyme deficiency disease; implantable delivery systems comprised of sustainable release drugs for treatment for central nervous disorders, cancer, hematological disorders, endocrine disorders, metabolic disorders, inflammatory disorders, gastrointestinal disorders, liver disease, heart disorders, lung and bronchial disease, blood cardiovascular diseases, circulatory system disease, intestinal disorders, bone disease, autoimmune disorders and disorders of the immune systems, infectious disease and enzyme deficiency disease; and anti-cancer vaccines |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, February 12, 2002 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Titan Pharmaceuticals, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | South San Francisco, CA 94080 |
Party Name | Titan Pharmaceuticals, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | South San Francisco, CA 94080 |
Event Date | Event Description |
Wednesday, June 20, 2007 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
Wednesday, June 20, 2007 | ABANDONMENT - NO USE STATEMENT FILED |
Wednesday, September 20, 2006 | EXTENSION 5 GRANTED |
Wednesday, September 20, 2006 | EXTENSION 5 FILED |
Wednesday, September 20, 2006 | TEAS EXTENSION RECEIVED |
Wednesday, March 22, 2006 | EXTENSION 4 GRANTED |
Wednesday, March 22, 2006 | EXTENSION 4 FILED |
Wednesday, March 22, 2006 | TEAS EXTENSION RECEIVED |
Wednesday, September 14, 2005 | EXTENSION 3 GRANTED |
Wednesday, September 14, 2005 | EXTENSION 3 FILED |
Wednesday, September 14, 2005 | TEAS EXTENSION RECEIVED |
Tuesday, April 5, 2005 | EXTENSION 2 GRANTED |
Tuesday, April 5, 2005 | EXTENSION 2 FILED |
Tuesday, April 5, 2005 | TEAS EXTENSION RECEIVED |
Monday, October 4, 2004 | EXTENSION 1 GRANTED |
Tuesday, September 21, 2004 | EXTENSION 1 FILED |
Tuesday, September 21, 2004 | TEAS EXTENSION RECEIVED |
Wednesday, June 23, 2004 | CASE FILE IN TICRS |
Tuesday, April 6, 2004 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
Monday, October 6, 2003 | EXTENSION OF TIME TO OPPOSE RECEIVED |
Tuesday, August 19, 2003 | PUBLISHED FOR OPPOSITION |
Wednesday, July 30, 2003 | NOTICE OF PUBLICATION |
Thursday, June 19, 2003 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, May 14, 2003 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, May 14, 2003 | PAPER RECEIVED |
Thursday, March 6, 2003 | FINAL REFUSAL MAILED |
Wednesday, December 11, 2002 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, December 11, 2002 | PAPER RECEIVED |
Friday, June 7, 2002 | NON-FINAL ACTION MAILED |
Thursday, June 6, 2002 | ASSIGNED TO EXAMINER |
Thursday, May 9, 2002 | ASSIGNED TO EXAMINER |